94 results
424B5
TCRX
Tscan Therapeutics Inc
17 Apr 24
Prospectus supplement for primary offering
9:58pm
executive compensation and performance and comparisons of the chief executive officer’s compensation to median employee compensation; and
not being … common stock reserved for the future issuance under our 2021 Employee Stock Purchase Plan, or the 2021 ESPP; and
47,010,526 shares of voting common
8-K
EX-1.1
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
subsidiaries or controlled affiliates, or any director, officer, or employee thereof, or, to the Company’s knowledge, any agent or representative … government official (including any officer or employee of a government or government-owned or controlled entity or of a public international
424B5
peflgq8ewhl
16 Apr 24
Prospectus supplement for primary offering
5:21pm
S-8
tgp2t df1qqf
6 Mar 24
Registration of securities for employees
4:05pm
S-8
EX-5.1
2yu1sfu 2u02
6 Mar 24
Registration of securities for employees
4:05pm
S-8
rdoh0l rc3gr
6 Mar 24
Registration of securities for employees
4:05pm
8-K
7bytoe3km
7 Dec 23
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
7:15am